WUHAN, CHINA - JANUARY 22: (CHINA OUT) Security personnel check the temperature of passengers in the Wharf at the Yangtze River on January 22, 2020 in Wuhan, Hubei province, China. A new infectious coronavirus known as "2019-nCoV" was discovered in Wuhan as the number of cases rose to over 400 in mainland China.
The outcomes of clinical trials conducted by medical authorities in China suggest that a drug used in Japan to treat new strands of the influenza appears to be effective in coronavirus patients.
Zhang Xinmin, an official at China’s science and technology ministry, told reporters on Tuesday that the drug favipiravir has “a high degree of safety and is clearly effective in treatment.”
Patients who were given the medicine during trials turned negative after an average of four days after contracting the virus. In comparison, those who were not treated with the drug turned negative after an average of 11 days.
Researchers also found that the lung condition of patients improved about 91% of the patients who were given the drug, compared to 62% of patients who did not take it.
Results of the trials suggest that the drug is not effective in treating patients with more severe symptoms of the virus.
The trials involved 340 patients in total.
Fujifilm Toyama Chemical, which developed favipiravir in 2014, has declined to comment.
"I can also say that I think President Biden made an enormous error. He should…
Curry now claims that the incident had caused him to experience "freezing, losing all motor…
Trump has previously shown love for bikers, once stating, "Do we love the bikers? Yes.…
Pope Francis called out "conservative critics" for having a "suicidal attitude" in a new interview.…
Gomez, known for her roles in Only Murders in the Building and her successful music career, stunned…
Trump seems to be retracting his support for Covid vaccines after Kennedy has been attracting…